Oxtoby Andrew

CIK 00017654733 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001765473

Recent Transactions

20 trades

Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2025-04-10+287,000→ 287,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (right to buy)
2025-03-18+476,611→ 476,611 total
Disposition to Issuer
CHINOOK THERAPEUTICS, INC.
Stock Option (Right to Buy)
2023-08-11$18.18/sh−160,000→ 0 total
Disposition to Issuer
CHINOOK THERAPEUTICS, INC.
Restricted Stock Units
2023-08-11−40,000→ 0 total
Award
CHINOOK THERAPEUTICS, INC.
Restricted Stock (RSU)(Common Stock)
2023-02-28+40,000→ 40,000 total
Award
CHINOOK THERAPEUTICS, INC.
Stock Option (right to buy)
2023-02-28+160,000→ 160,000 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$12.56/sh−150,000→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-13$34.50/sh−20,250→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$10.69/sh−67,500→ 0 total
Disposition from Tender
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-10$34.50/sh−6,345→ 0 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-09-15$34.25/sh−840→ 26,595 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-05-10+2,420→ 27,435 total
Purchase
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-03-13$14.76/sh+3,000→ 25,015 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-02-28+11,250→ 22,015 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-02-28+67,500→ 67,500 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-02-28+67,500→ 67,500 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-02-28+11,250→ 23,250 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-01-22$33.23/sh−1,235→ 10,765 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-01-22+150,000→ 150,000 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-01-22+12,000→ 12,000 total

Companies

Recent Filings

Address

C/O KALARIS THERAPEUTICS, INC. 628 MIDDLEFIELD ROAD

PALO ALTO, CA, 94301

View on SEC.gov